Linda Doerrer, Paul Lipton lend scientific thought to “visionary” curriculum.
Arvind and Chandan Nandlal Kilachand Professor and Director Charles Dellheim is delighted to announce the appointment of David Winer as Executive in Residence for Kilachand Honors College.
Winer, president of Winer Capital, is excited to join Boston University’s Kilachand Honors College as Executive in Residence. He graduated from Hamilton College with a bachelor’s degree in economics and a minor in Chinese. Following graduation, he worked at Goldman Sachs as an analyst in the Investment Banking Division. Winer was recruited from Goldman Sachs to work for a fund in Boston, where he was the youngest person promoted to running a group. He ran the only profitable group in 2008 and the most profitable group in 2009. In 2010, he established his own privately held firm, Winer Capital Management, LLC. He teaches a finance course at the Questrom School of Business and is the advisor to Boston University’s Public Markets Investing Group.
“There’s such an incredible volume of material streaming into people all day long that one of the challenges is, how do you sort it out?” observes Carroll.
“When I was growing up,” says Zaman, “I was taught that the sources of all ills in our society are zarr, zameen aur zann (money, land, and women). Unfortunately, little has changed in our attitudes in the last couple of decades. But it can change and it must change. We have to reject, individually and collectively, these cultural notions of misogyny.”
“In some ways, the modern myth of Thoreau doesn’t do the author justice,” says Primack.
Professor of Biomedical Engineering Muhammad Zaman has been featured on NPR in the article “One Man’s Quest to Combat Counterfeit Drugs—With a Suitcase.” Professor Zaman has designed a device about the size of a carry-on bag, called PharmaChk, that detects counterfeit drugs. In 2014, Professor Zaman won a $2 million grant from Saving Lives at Birth to bring PharmaChk closer to commercial production.